Close Menu

NEW YORK – Bio-Rad Laboratories disclosed in a Form 8-K filed with the US Securities and Exchange Commission on Friday that it was the victim of a ransomware attack on its network the day before.

The firm declared that it immediately took certain systems offline and is now working to restore full system functionality. "Customers may experience delays in placing orders while Bio-Rad’s systems are down," the firm wrote, but also said that there is currently no evidence of any unauthorized transfer or misuse of data.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.